Skip to main content
. Author manuscript; available in PMC: 2013 Mar 11.
Published in final edited form as: J Immunol. 2011 Feb 14;186(6):3401–3409. doi: 10.4049/jimmunol.1000328

FIGURE 7.

FIGURE 7

Analysis of NK cell activation status. A, Immunofluorescent microscopy for CD335 (NKp46, an NK cell activation marker, in red) in tumors of treated mice. Tumor sections counterstained with DAPI for nuclear identification. Original magnification ×40. B, Flow cytometry for CD49b and CD69 in the splenocytes of treated mice.